N@N

SELF Magazine Honors Obagi Medical Products with a 2011 Healthy Beauty Award

^{Published on 2011-04-27 14:50:58 - Market Wire}
 

LONG BEACH, Calif.--([ BUSINESS WIRE ])--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, announces its new Nu-Derm Sun Shield SPF 50 as aSELF Magazine 2011 Healthy Beauty Awards winner.The Obagi Nu-Derm Sun Shield SPF 50, an elegant line extension to Obagi Medicala™s top-selling Nu-Derm line, was named the winner in the Best Sunscreen for Face, SPF 50+ category.

"After working to meet the requests of our end-users for an elegant, high protection sunscreen lotion that really can be used every day, we are thrilled to be recognized as the Best Sunscreen for Face, in the SPF 50+ category"

aAfter working to meet the requests of our end-users for an elegant, high protection sunscreen lotion that really can be used every day, we are thrilled to be recognized as the Best Sunscreen for Face, in the SPF 50+ category,a Jim Hartman, Vice President of Global Marketing and Business Development at Obagi Medical, said. aThank you to SELF Magazine for integrating their readersa™ real life experience with the product a" it is rewarding to hear about their positive experience with Nu-Derm Sun Shield.a

SELF Magazine asked their top beauty experts a" their readers a" to test the preeminent product launches of 2011 and select those worthy of the title aSELF 2011 Healthy Beauty Award Winner.a More than 2,200 women tested 1,187 products, choosing the Obagi Nu-Derm Sun Shield SPF 50 as the favorite sunscreen launch product for face with SPF 50+. The Nu-Derm Sun Shield SPF 50 combines UVB absorption and UVA blockage for high sunscreen protection in an elegant, matte finish that can be used on nearly all skin types with or without makeup. Nu-Derm Sun Shield SPF 50 features the active ingredients Zinc Oxide (10.5%) and Octinoxate (7.5%) and provides complete anti-aging sun protection.

About Obagi Medical Products, Inc.

Obagi Medical Products is a specialty pharmaceutical company that develops, markets and sells, and is a leading provider of, proprietary topical aesthetic and therapeutic prescription-strength skin care systems in the physician-dispensed market. Using its Penetrating Therapeuticsa" technologies, Obagi Medical's products are designed to improve penetration of agents across the skin barrier for common and visible skin conditions in adult skin including premature aging, photodamage, hyperpigmentation (irregular or patchy discoloration of the skin), acne, sun damage, rosacea, and soft tissue deficits, such as fine lines and wrinkles. The history of Obagi's skin care product introductions is as follows: Obagi Nu-Derm®, Obagi-C® Rx (a prescription-strength vitamin C and hydroquinone system), Obagi® Professional-C (a line of highly stable vitamin C serums), Obagi Condition &Enhance® for use with cosmetic procedures to enhance patient outcomes and satisfaction, Obagi ELASTIderm® Eye Treatment and Obagi CLENZIderm® M.D. acne therapeutic systems, a formulation of Obagi CLENZIderm M.D. Systems for normal to dry skin, and Obagi ELASTIderm D©colletage System, Obagi Rosaclear® System, Obagi ELASTILasha" Eyelash Solution, Obagi Blue Peel RADIANCE^TM, and Nu-Derm® Sun Shield SPF 50. Visit [ www.obagi.com ] for information.

Blue Peel RADIANCE, ELASTIlash and Penetrating Therapeutics are trademarks, and Obagi, Blue Peel, Condition & Enhance, ELASTIderm, Nu-Derm, Obagi-C, Obagi CLENZIderm and Rosaclear are registered trademarks, of Obagi Medical Products, Inc. and/or its affiliates in the United States and certain other countries.